Researchers have demonstrated that antibiotic-resistance plasmids persist in the absence of antibiotics, provided that the efficiency of plasmid transfer exceeds a critical threshold, highlighting the limitations of ‘resistance-reversal’ strategies.
On the occasion of World AIDS Day 2017, the ISNTD is launching the disease report: “Female Genital Schistosomiasis: the most neglected gynaecological disease”, highlighting the linkages with HIV and calling for accelerating advocacy, policy and intervention collaboration.
To date there have only been a handful of Phase III efficacy trials for HIV vaccine candidates, which have had varied, and in some cases controversial, results. Here we review the history of HIV vaccine efficacy studies and look into the vaccine candidates closest to front-line use.
Continuing our focus on antimicrobial resistance, Editor, Martha Powell, takes a closer look at the steps that can be taken to prevent the spread of drug resistance.
Take a look at the Storify of our Twitter chat #TalkAMR and catch up on all the great content!
In this infographic we summarize the clinical candidates reported by the WHO – indicating which diseases they are active (or possibly active) against, whether they’re considered innovative and which Phase the trials are currently in.
Read our note from the Editor and browse some of our top, exclusive content on antimicrobial resistance in line with World Antibiotic Awareness Week.
A recently published study has uncovered how an antibiotic that targets a metabolic pathway to starve bacteria of a nutrient can lead to cell death, shedding light on the downstream effects that can account for toxicity.